Research Identifies Genetic Predictor of Weight Loss with GLP-1RAs

Research identifies genetic predictor of weight loss with GLP-1RAs

A new study published by Cleveland Clinic researchers in Diabetes, Obesity and Metabolism investigating the genetic underpinnings of weight loss response has identified a gene, neurobeachin (NBEA), as a predictor of how individuals respond to GLP-1RAs, the class of medications behind popular treatments like liraglutide and semaglutide.

MetP Pharma releases positive data on intranasal semaglutide administration - Pharmafile

MetP Pharma has released new data highlighting the advantages of its MetP technology in delivering neuroactive peptides, particularly semaglutide, directly to the brain though the intranasal route. This opens up the possibility of the platform being used for a wide range of neuroactive therapeutics, from metabolic to neurodegenerative diseases. The data demonstrates that the MetP […] The post MetP Pharma releases positive data on intranasal sema…

What is Wegovy and how does it work for weight loss?

In the quest for effective and sustainable weight loss solutions, Wegovy has emerged as a revolutionary medication that is transforming the way people approach chronic weight management. Especially gaining traction in places like Dubai, where lifestyle-related weight challenges are prevalent, Wegovy offers a scientifically backed approach to shedding pounds in a healthier and more manageable way. But what exactly is Wegovy, and how does it funct…